Figure 1.
Relationship between change in apoA-I production rate and change in cholesterol efflux capacity after 8 weeks of therapy with either LY518674 or placebo.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.